Sveriges mest populära poddar
What Next: TBD | Tech, power, and the future

The Rise of Off-Brand Ozempic

19 min18 augusti 2024

GLP-1 drugs like Ozempic and Wegovy are in high demand and short supply. The internet makes it easy for you to have a compounding pharmacy whip you up a batch—but should you?


Guest: Kate Knibbs, senior writer at Wired. 


Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.

Need to set up your Slate Plus feed? If you subscribed through Slate.com, check out our FAQ at slate.com/podcastfaqs for easy instructions. Members subscribed via Apple Podcasts get automatic access—no setup required.


Hosted on Acast. See acast.com/privacy for more information.

Fler avsnitt av What Next: TBD | Tech, power, and the future

Visa alla avsnitt av What Next: TBD | Tech, power, and the future

What Next: TBD | Tech, power, and the future med Slate Podcasts finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.